Biomaterials Market Report Scope & Overview:

The Biomaterials Market size was estimated USD 156.1 billion in 2022 and is expected to reach USD 501.2 billion by 2030 at a CAGR of 15.7% during the forecast period of 2023-2030. 

Biomaterial refers to any substance or mixture of substances that can be synthetic or natural in origin. Biomaterials research is the study of biomaterials, which includes factors such as genetics, medicine, chemistry, and tissue engineering. These biomaterials communicate with biological systems in order to cure cardiovascular, dental, orthopaedic, and neurological disorders.

Biomaterials Market Revenue Analysis



  • Rising demand for biomaterials in plastic surgery and wound healing applications

Plastic surgery and wound healing are two of the most prevalent applications for biomaterial-based products. Biomaterials are widely used in plastic surgery for implanting, reconstructing, healing, and concealing soft-tissue wounds, burns, or gaping holes in the human body in a natural and safe manner. In the future years, demand for biomaterials in plastic surgery and wound healing applications will be driven by innovations and technological breakthroughs, as well as the increased popularity of aesthetic cosmetic procedures.


  • Stringent clinical & regulatory processes

Biomaterial-based medical devices are strictly controlled in numerous places, including North America, Europe, and Asia, to assure their quality and efficacy. This is primarily due to the fact that majority of biomaterial-based medical devices are implantable. Before they can be marketed, all new biomaterials must demonstrate that they are safe and effective. In the United States, the FDA establishes tight criteria and regulations for the clearance procedure. Biomaterial-based products, such as implantable pacemakers, stents, and cardiac valves, are categorized as Class III devices by the FDA, posing the highest risk of sickness or harm. As a result, these devices are submitted to the premarket approval application process (the most stringent sort of device marketing application).


  • Increasing healthcare markets in emerging economies

The biomaterials market in emerging nations is predicted to increase significantly during the projected period. This can be attributed primarily to these countries' growing patient populations, increasing adoption of implantable devices, growing awareness of CVDs, rising disposable income, improving healthcare infrastructure, and the presence of less stringent regulatory guidelines (in comparison to developed countries).


  • Stringent guidelines and compatibility issues


The Russian-Ukrainian situation appears to be exacerbating the pandemic's impact on Ukrainian health, particularly mental health. Knowing that Ukraine's health-care system was substantial but frail. And, in the midst of the continuing COVID-19 pandemic, which has already put health systems and health care personnel under immense strain, such attacks have the potential to be considerably more disastrous for Ukraine. SURVEILLANCE SYSTEM FOR ATTACKS ON HEALTH CARE (SSA) reported an anticipated 158 attacks on health care facilities until the end of April 2022.


Covalon Technologies Ltd. maintains a modest direct sales organization in the United States that sells directly to acute care hospitals and related institutions. Companies' sales staff has had to adjust and modify their strategy as COVID-19 limits have been imposed on hospitals and those who can enter hospitals. As a result, their sales force has limited access to these customers. As a result of the impact of COVID-19 and the continuous slump in market conditions, they withdrew sales force in the United Kingdom and are now focusing on growth in the United States market.


By Product

  • Metallic

  • Natural

  • Ceramics

  • Polymers

In 2022, Polymers segment is expected to held the highest market share of 28.5% during the forecast period owing to the wide range of product usage. Moreover, the widespread availability of biopolymers and advanced polymers for bio-resorbable tissue fixation and other orthopedic applications is likely to increase the segment's revenue growth. Polymeric biomaterials are a key component in tissue engineering. Micro-manufacturing, surface modification, drug delivery, nanotechnology, and high-throughput screening are all contributing to the expansion of polymeric material utilization in the tissue engineering sector.

By Application

  • Cardiovascular

    • Sensors

    • Stents

    • Guidewires

    • Implantable Cardiac Defibrillators

    • Pacemakers

    • Vascular Grafts

    • Others

  • Ophthalmology

    • Synthetic Corneas

    • Intraocular Lens

    • Contact Lens

    • Ocular Tissue Replacement

    • Others

  • Dental

    • Tissue Regeneration Materials

    • Dental Implants

    • Bone Grafts & Substitutes

    • Dental Membranes

    • Others

  • Orthopedic

    • Joint Replacement Biomaterials

    • Orthobiologics

    • Bioresorbable Tissue Fixation Products

    • Viscosupplementation

    • Spine Biomaterials

    • Others

  • Wound Healing

    • Fracture Healing Device

    • Adhesion Barrier

    • Skin Substitutes

    • Internal Tissue Sealant

    • Surgical Hemostats

    • Others

  • Tissue Engineering

  • Plastic Surgery

    • Facial Wrinkle Treatment

    • Soft Tissue Fillers

    • Craniofacial Surgery

    • Bioengineered Skins

    • Peripheral Nerve Repair

    • Acellular Dermal Matrices

    • Others

  • Neurology

    • Neural Stem Cell Encapsulation

    • Shunting Systems

    • Hydrogel Scaffold for CNS Repair

    • Cortical Neural Prosthetics

    • Others

  • Others

Biomaterials Market Segmentation Analysis

In 2022, Orthopedic segment is expected to dominate the market growth of 23.2% during the forecast period due to their high load-bearing capacity. Also, market vendors' ongoing efforts to introduce innovative orthopedic implants are projected to drive revenue generation.


North America held a significant market share of around 38.2% in 2022 owing to the measures performed by various governmental and private organizations. The National Science Foundation and the National Institute of Standards and Technology, which give expertise and help on the use of biomaterials in biological applications. As a result, the usage of biomaterials in this region has expanded. Furthermore, favorable government policies and the presence of numerous big market players in this region have aided the regional market share.

Asia-Pacific is witness to expand fastest CAGR rate of 16.8% during the forecast period due to strategic initiativews adopted by the regional companies to reinforce their presence in local as well as global markets, Also, the biomaterials market in India is constantly booming. The orthopedic, dental, and cardiovascular biomaterials industries dominate the Indian biomaterials business.


North America

  • US

  • Canada

  • Mexico


  • Eastern Europe

    • Poland

    • Romania

    • Hungary

    • Turkey

    • Rest of Eastern Europe

  • Western Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Netherlands

    • Switzerland

    • Austria

    • Rest of Western Europe

Asia Pacific

  • China

  • India

  • Japan

  • South Korea

  • Vietnam

  • Singapore

  • Australia

  • Rest of Asia Pacific

Middle East & Africa

  • Middle East

    • UAE

    • Egypt

    • Saudi Arabia

    • Qatar

    • Rest of Middle East

  • Africa

    • Nigeria

    • South Africa

    • Rest of Africa

Latin America

  • Brazil

  • Argentina

  • Colombia

  • Rest of Latin America

Key Players

The major key players are Medtronic plc, Evonik Industries AG, Carpenter Technology Corporation, Berkeley Advanced Biomaterials, Invibio Ltd., Zimmer Biomet Holdings, Inc., BASF SE, Covalon Technologies Ltd., Stryker, Johnson & Johnson, Dentsply Sirona, CoorsTek Inc., GE Healthcare, Collagen Matrix, Inc., and Others.

Medtronic plc-Company Financial Analysis

Company Landscape Analysis


  • Evonik Industries AG, in March 2022, EUDRATEC Fasteric, a platform for oral drug delivery technology that goes directly over the released target and is used for enteric fortification and rapid release in the upper smaller intestine, was formally introduced by Evonik Industries. This product development aided Evonik's growth by improving the biocompatibility, safety, and functioning of implanted items used by medical device customers.

  • Medtronic and GE Healthcare, in April 2022, Medtronic and GE Healthcare formed a cooperation to satisfy the particular needs and demand for care in ambulatory surgery centers (ASCs) and office-based laboratories. (OBLs). Customers will benefit from a wide selection of products, financial options, and exceptional assistance as a result of this new relationship.

Biomaterials Market Report Scope:
Report Attributes Details
Market Size in 2022  US$ 156.1 Billion
Market Size by 2030  US$ 501.2 Billion
CAGR   CAGR of 15.7 % From 2023 to 2030
Base Year 2022
Forecast Period  2023-2030
Historical Data  2019-2021
Report Scope & Coverage Market Size, Segments Analysis, Competitive  Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook
Key Segments • By Product (Metallic, Natural, Ceramics, Polymers)
• By Application (Cardiovascular, Ophthalmology, Dental, Orthopedic, Wound Healing, Tissue Engineering, Plastic Surgery, Neurology, Others)
Regional Analysis/Coverage North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America)
Company Profiles Medtronic plc, Evonik Industries AG, Carpenter Technology Corporation, Berkeley Advanced Biomaterials, Invibio Ltd., Zimmer Biomet Holdings, Inc., BASF SE, Covalon Technologies Ltd., Stryker, Johnson & Johnson, Dentsply Sirona, CoorsTek Inc., GE Healthcare, Collagen Matrix, Inc.
Key Drivers • Rising demand for biomaterials in plastic surgery and wound healing applications
Market Opportunity • Increasing healthcare markets in emerging economies


Frequently Asked Questions

Ans: Biomaterials Market is anticipated to expand by 15.7% from 2023 to 2030.

Ans:  USD 501.2 billion is expected to grow by 2030.

Ans: Biomaterials Market size was valued at USD 156.1 billion in 2022.

Ans: North America is dominating the market.

Ans: Increasing demand for biomaterials in plastic surgery and wound healing applications


1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions

2. Research Methodology

3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 Impact of the Russia-Ukraine War
4.2 Impact of Ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies US Canada Germany France United Kingdom China Japan South Korea Rest of the World

5. Value Chain Analysis

6. Porter’s 5 forces model

7. PEST Analysis

8. Biomaterials Market Segmentation, By Product
8.1 Metallic
8.2 Natural
8.3 Ceramics
8.4 Polymers

9. Biomaterials Market Segmentation, By Application
9.1 Cardiovascular
9.1.1 Sensors
9.1.2 Stents
9.1.3 Guidewires
9.1.4 Implantable Cardiac Defibrillators
9.1.5 Pacemakers
9.1.6 Vascular Grafts
9.1.7 Others
9.2 Ophthalmology
9.2.1 Synthetic Corneas
9.2.2 Intraocular Lens
9.2.3 Contact Lens
9.2.4 Ocular Tissue Replacement
9.2.5 Others
9.3 Dental
9.3.1 Tissue Regeneration Materials
9.3.2 Dental Implants
9.3.3 Bone Grafts & Substitutes
9.3.4 Dental Membranes
9.3.5 Others
9.4 Orthopedic
9.4.1 Joint Replacement Biomaterials
9.4.2 Orthobiologics
9.4.3 Bioresorbable Tissue Fixation Products
9.4.4 Viscosupplementation
9.4.5 Spine Biomaterials
9.4.6 Others
9.5 Wound Healing
9.5.1 Fracture Healing Device
9.5.2 Adhesion Barrier
9.5.3 Skin Substitutes
9.5.4 Internal Tissue Sealant
9.5.5 Surgical Hemostats
9.6 Tissue Engineering
9.7 Plastic Surgery
9.7.1 Facial Wrinkle Treatment
9.7.2 Soft Tissue Fillers
9.7.3 Craniofacial Surgery
9.7.4 Bioengineered Skins
9.7.5 Peripheral Nerve Repair
9.7.6 Acellular Dermal Matrices
9.7.7 Others
9.8 Neurology
9.8.1 Neural Stem Cell Encapsulation
9.8.2 Shunting Systems
9.8.3 Hydrogel Scaffold for CNS Repair
9.8.4 Cortical Neural Prosthetics
9.8.5 Others
9.9 Others

10. Regional Analysis
10.1 Introduction
10.2 North America
10.2.1 North America Biomaterials Market by Country
10.2.2 North America Biomaterials Market by Product
10.2.3 North America Biomaterials Market by Application
10.2.4 USA USA Biomaterials Market by Product USA Biomaterials Market by Application
10.2.5 Canada Canada Biomaterials Market by Product Canada Biomaterials Market by Application
10.2.6 Mexico Mexico Biomaterials Market by Product Mexico Biomaterials Market by Application
10.3 Europe
10.3.1 Eastern Europe Eastern Europe Biomaterials Market by Country Eastern Europe Biomaterials Market by Product Eastern Europe Biomaterials Market by Application Poland Poland Biomaterials Market by Product Poland Biomaterials Market by Application Romania Romania Biomaterials Market by Product Romania Biomaterials Market by Application Hungary Hungary Biomaterials Market by Product Hungary Biomaterials Market by Application Turkey Turkey Biomaterials Market by Product Turkey Biomaterials Market by Application Rest of Eastern Europe Rest of Eastern Europe Biomaterials Market by Product Rest of Eastern Europe Biomaterials Market by Application
10.3.2 Western Europe Western Europe Biomaterials Market by Country Western Europe Biomaterials Market by Product Western Europe Biomaterials Market by Application Germany Germany Biomaterials Market by Product Germany Biomaterials Market by Application France France Biomaterials Market by Product France Biomaterials Market by Application UK UK Biomaterials Market by Product UK Biomaterials Market by Application Italy Italy Biomaterials Market by Product Italy Biomaterials Market by Application Spain Spain Biomaterials Market by Product Spain Biomaterials Market by Application Netherlands Netherlands Biomaterials Market by Product Netherlands Biomaterials Market by Application Switzerland Switzerland Biomaterials Market by Product Switzerland Biomaterials Market by Application Austria Austria Biomaterials Market by Product Austria Biomaterials Market by Application Rest of Western Europe Rest of Western Europe Biomaterials Market by Product Rest of Western Europe Biomaterials Market by Application
10.4 Asia-Pacific
10.4.1 Asia Pacific Biomaterials Market by Country
10.4.2 Asia Pacific Biomaterials Market by Product
10.4.3 Asia Pacific Biomaterials Market by Application
10.4.4 China China Biomaterials Market by Product China Biomaterials Market by Application
10.4.5 India India Biomaterials Market by Product India Biomaterials Market by Application
10.4.6 Japan Japan Biomaterials Market by Product Japan Biomaterials Market by Application
10.4.7 South Korea South Korea Biomaterials Market by Product South Korea Biomaterials Market by Application
10.4.8 Vietnam Vietnam Biomaterials Market by Product Vietnam Biomaterials Market by Application
10.4.9 Singapore Singapore Biomaterials Market by Product Singapore Biomaterials Market by Application
10.4.10 Australia Australia Biomaterials Market by Product Australia Biomaterials Market by Application
10.4.11 Rest of Asia-Pacific Rest of Asia-Pacific Biomaterials Market by Product Rest of Asia-Pacific APAC Biomaterials Market by Application
10.5 Middle East & Africa
10.5.1 Middle East Middle East Biomaterials Market by Country Middle East Biomaterials Market by Product Middle East Biomaterials Market by Application UAE UAE Biomaterials Market by Product UAE Biomaterials Market by Application Egypt Egypt Biomaterials Market by Product Egypt Biomaterials Market by Application Saudi Arabia Saudi Arabia Biomaterials Market by Product Saudi Arabia Biomaterials Market by Application Qatar Qatar Biomaterials Market by Product Qatar Biomaterials Market by Application Rest of Middle East Rest of Middle East Biomaterials Market by Product Rest of Middle East Biomaterials Market by Application
10.5.2 Africa Africa Biomaterials Market by Country Africa Biomaterials Market by Product Africa Biomaterials Market by Application Nigeria Nigeria Biomaterials Market by Product Nigeria Biomaterials Market by Application South Africa South Africa Biomaterials Market by Product South Africa Biomaterials Market by Application Rest of Africa Rest of Africa Biomaterials Market by Product Rest of Africa Biomaterials Market by Application
10.6 Latin America
10.6.1 Latin America Biomaterials Market by Country
10.6.2 Latin America Biomaterials Market by Product
10.6.3 Latin America Biomaterials Market by Application
10.6.4 Brazil Brazil Biomaterials Market by Product Brazil Biomaterials Market by Application
10.6.5 Argentina Argentina Biomaterials Market by Product Argentina Biomaterials Market by Application
10.6.6 Colombia Colombia Biomaterials Market by Product Colombia Biomaterials Market by Application
10.6.7 Rest of Latin America Rest of Latin America Biomaterials Market by Product Rest of Latin America Biomaterials Market by Application

11. Company Profile
11.1 Medtronic plc
11.1.1 Company Overview
11.1.2 Financials
11.1.3 Product/Products Offered
11.1.4 SWOT Analysis
11.1.5 The SNS View
11.2 Evonik Industries AG
11.2.1 Company Overview
11.2.2 Financials
11.2.3 Product/Products Offered
11.2.4 SWOT Analysis
11.2.5 The SNS View
11.3 Carpenter Technology Corporation
11.3.1 Company Overview
11.3.2 Financials
11.3.3 Product/Products Offered
11.3.4 SWOT Analysis
11.3.5 The SNS View
11.4 Berkeley Advanced Biomaterials
11.4.1 Company Overview
11.4.2 Financials
11.4.3 Product/Products Offered
11.4.4 SWOT Analysis
11.4.5 The SNS View
11.5 Invibio Ltd.
11.5.1 Company Overview
11.5.2 Financials
11.5.3 Product/Products Offered
11.5.4 SWOT Analysis
11.5.5 The SNS View
11.6 Zimmer Biomet Holdings, Inc.,
11.6.1 Company Overview
11.6.2 Financials
11.6.3 Product/Products Offered
11.6.4 SWOT Analysis
11.6.5 The SNS View
11.7 BASF SE
11.7.1 Company Overview
11.7.2 Financials
11.7.3 Product/Products Offered
11.7.4 SWOT Analysis
11.7.5 The SNS View
11.8 Covalon Technologies Ltd.
11.8.1 Company Overview
11.8.2 Financials
11.8.3 Product/Products Offered
11.8.4 SWOT Analysis
11.8.5 The SNS View
11.9 Stryker
11.9.1 Company Overview
11.9.2 Financials
11.9.3 Product/ Products Offered
11.9.4 SWOT Analysis
11.9.5 The SNS View
11.10 Johnson & Johnson
11.10.1 Company Overview
11.10.2 Financials
11.10.3 Product/Products Offered
11.10.4 SWOT Analysis
11.10.5 The SNS View
11.11 Dentsply Sirona
11.11.1 Company Overview
11.11.2 Financials
11.11.3 Product/Products Offered
11.11.4 SWOT Analysis
11.11.5 The SNS View
11.12 CoorsTek Inc.
11.12.1 Company Overview
11.12.2 Financials
11.12.3 Product/Products Offered
11.12.4 SWOT Analysis
11.12.5 The SNS View
11.13 GE Healthcare
11.13.1 Company Overview
11.13.2 Financials
11.13.3 Product/Products Offered
11.13.4 SWOT Analysis
11.13.5 The SNS View
11.14 Collagen Matrix, Inc.
11.14.1 Company Overview
11.14.2 Financials
11.14.3 Product/Products Offered
11.14.4 SWOT Analysis
11.14.5 The SNS View
11.15 Others

12. Competitive Landscape
12.1 Competitive Bench marking
12.2 Market Share Analysis
12.3 Recent Developments
12.3.1 Industry News
12.3.2 Company News
12.3.3 Mergers & Acquisitions

13. USE Cases and Best Practices

14. Conclusion

An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.

Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.


The 5 steps process:

Step 1: Secondary Research:

Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.

Secondary Research

Step 2: Primary Research

When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data.  This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.

We at SNS Insider have divided Primary Research into 2 parts.

Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.

This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.

Primary Research

Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.

Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.

Step 3: Data Bank Validation

Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.

Data Bank Validation

Step 4: QA/QC Process

After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.

Step 5: Final QC/QA Process:

This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.

Start a Conversation

Hi! Click one of our member below to chat on Phone